Key Articles and Guidelines Relative to Intensive Care Unit Pharmacotherapy: 2009 Update

Brian L. Erstad, Pharm.D., FCCM, FCCP, FASHP; Gretchen M. Brophy, Pharm.D., FCCP, FCCM; Steven J. Martin, Pharm.D., FCCP, FCCM; Curtis E. Haas, Pharm.D., FCCP; John W. Devlin, Pharm.D., FCCM, FCCP; Lynda S. Welage, Pharm.D., FCCP; William E. Dager, Pharm.D., FCSHP, FCCP, FCCM


Pharmacotherapy. 2009;29(10):1228-1269. 

In This Article

Medication Errors and Adverse Drug Events in the Intensive Care Unit

Thomas AN, Panchagnula U. Medication-related patient safety incidents in critical care: a review of reports to the UK National Patient Safety Agency. Anaesthesia 2008;63:726–33.

Kane-Gill S, Rea RS, Verrico MM, Weber RJ. Adverse-drug-event rates for high-cost and high-use drugs in the intensive care unit. Am J Health Syst Pharm 2006;63:1876–81.

Pronovost PJ, Thompson DA, Holzmueller CG, et al. Toward learning from patient safety reporting systems. J Crit Care 2006;21:305–15.

Rothschild JM, Landrigan CP, Cronin JW, et al. The critical care safety study: the incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med 2005;33:1694–700.

Osmon S, Harris CB, Dunagan C, Prentice D, Fraster VJ, Kollef MH. Reporting of medication errors: an intensive care unit experience. Crit Care Med 2004;32:727–33.

Vargas E, Terleira A, Hernando F, et al. Effect of adverse drug reactions on length of stay in surgical intensive care units. Crit Care Med 2003;31:694–8.

van den Bemt PM, Fijn R, van der Voort PH, Gossen AA, Egberts TC, Brouwers JR. Frequency and determinants of drug administration errors in the intensive care unit. Crit Care Med 2002;30:846–50.

Calabrese AD, Erstad BL, Brandl K, Barletta JF, Kane SL, Sherman DS. Medication administration errors in adult patients in the ICU. Intensive Care Med 2001;27:1592–8.

Flaatten H, Hevroy O. Errors in the intensive care unit (ICU). Acta Anaesthesiol Scand 1999;43:614–17.

Tissot E, Cornette C, Demoly P, Jacquet M, Barale F, Capellier G. Medication errors at the administration stage in an intensive care unit. Intensive Care Med 1999;25:353–9.

Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267–70.

Vargas E, Simon J, Puerro M, et al. Effect of adverse drug reactions on length of stay in intensive care units. Clin Drug Invest 1998;15:353–60.

Schneider MP, Cotting J, Pannatier A. Evaluation of nurses' errors associated in the preparation and administration of medication in a pediatric intensive care unit. Pharm World Sci 1998;20:178–82.

Cullen DJ, Sweitzer BJ, Bates DW, Burdick E, Edmondson A, Leape LL. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med 1997;25:1289–97.

Donchin Y, Gopher D, Olin M, et al. A look into the nature and causes of human errors in the intensive care unit. Crit Care Med 1995;23:294–300.

Girotti MJ, Garrick C, Tierney MG, et al. Medication administration errors in an adult intensive care unit. Heart Lung 1987;16:449–53.

Tisdale JE. Justifying a pediatric critical-care satellite pharmacy by medication-error reporting. Am J Hosp Pharm 1986;43:368–71.

Abramson NS, Wald KS, Grenvik ANA, Robinson D, Snyder JV. Adverse occurrences in intensive care units. JAMA 1980;244:1582–4.